Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-30

Clinical Trial Update: An Alternative Dosing Schedule of Varenicline for Smoking Cessation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated an alternative dosing schedule of varenicline for smoking cessation. The study results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30